Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : UW School of Medicine and Public Health
Deal Size : Undisclosed
Deal Type : Collaboration
Cellares and UW School Collaborate to Automate CRISPR CAR-T Production
Details : The collaboration will automate the manufacturing of a CRISPR-edited GD2 CAR-T investigational therapy for solid tumors.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
April 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : UW School of Medicine and Public Health
Deal Size : Undisclosed
Deal Type : Collaboration